A systematic, updated review of Xuezhikang, a domestically …
2024年10月1日 · Xuezhikang, an extract of cholestin, is available from Chinese red yeast rice (RYR). Although monacolin K and lovastatin and its derivatives constitute the main active …
A systematic review of xuezhikang, an extract from red yeast rice, …
Xuezhikang showed significant benefit on the incidence of all-cause deaths, CHD deaths, myocardial infarction, and revascularization as compared with placebo based on conventional …
血脂康胶囊 - 百度百科
本品有调节异常血脂的作用，可降低血胆固醇、甘油三酯、低密 度脂蛋白胆固醇和升高高密度脂蛋白胆固醇；抑制动脉粥样硬化 斑块的形成；保护血管内皮细胞；抑制脂质在肝脏沉积。 密封 …
Xuezhikang, an Extract of Cholestin, Protects Endothelial Function ...
2004年8月16日 · Xuezhikang, an extract of Cholestin, a dietary supplement, has lipid-modulating and antiinflammatory effects. We explored the effects of xuezhikang on endothelial function …
血脂康 (Xuezhikang) - 药物靶点：HMG-CoA reductase_在研适应 …
Xuezhikang, a red yeast rice (RYR) extract, containing 13 kinds of monacolins and other bioactive components, emerges as one such promising option. Its discovery was built on a long history …
血脂康胶囊(北大维信)详细说明书-注意事项-不良反应-用法用量-39 …
汉语拼音：Xuezhikang Jiaonang 【成份】 红曲。 【性状】 本品为胶囊剂，内容物为紫红色的粉末；气微酸，味淡。 【功能主治】 除湿祛痰，活血化瘀，健脾消食。
绿叶制药集团血脂康（Xuezhikang(XZK)）美国FDA二期临床试验 …
从研究简述来看，这是一项多中心、双盲、随机、安慰剂对照、平行分组的临床试验，预计招募120名受试者，同时在美国和中国的10多个临床中心进行。 该临床试验有4周的 洗脱期，之后 …
Effects of Xuezhikang in patients with dyslipidemia: a multicenter ...
Daily XZK 1200 mg and 2400 mg for 4 to 12 weeks resulted in statistically significant (P < .001) and clinically meaningful decreases in non-HDL-C (∼24% reduction) and LDL-C (∼27% …
Xuezhikang, an extract of cholestin, reduces cardiovascular events …
Xuezhikang is an extract of cholestin and has a markedly modulating effect on lipids, but the effect of xuezhikang on reducing coronary events in diabetic patients with coronary heart disease …
Xuezhikang, an extract from red yeast rice, attenuates vulnerable ...
2017年11月30日 · Xuezhikang (XZK), an extract of red yeast rice, is a traditional Chinese medicine widely used for the treatment of cardiovascular diseases in China and other …